Clinical Trial Detail

NCT ID NCT03735628
Title An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bayer

hepatocellular carcinoma

Advanced Solid Tumor

colorectal cancer

lung non-small cell carcinoma

head and neck squamous cell carcinoma


Copanlisib + Nivolumab

Age Groups: adult senior

No variant requirements are available.